Fertility and Sterility
Volume 94, Issue 6 , Pages 2141-2146, November 2010

Semen characteristics and sperm DNA fragmentation in infertile men with low and high levels of seminal reactive oxygen species

Center for Reproductive Medicine, Glickman Urological & Kidney Institute, Cleveland Clinic, Cleveland, Ohio

Received 6 October 2009; received in revised form 4 December 2009; accepted 10 December 2009. published online 01 February 2010.

Objective

To examine sperm motility, total antioxidant level (TAC), DNA fragmentation, and medical history in infertile men with high seminal high reactive oxygen species (ROS).

Design

Prospective study.

Setting(s)

Tertiary care hospital.

Patient(s)

Infertile men (n = 101).

Intervention(s)

Group I (n = 57) included men with seminal ROS (<250 relative light units/sec/×106 sperm) while group II (n = 44) included men with seminal ROS levels (≥250 relative light units/sec/×106 sperm).

Main Outcome Measure(s)

Seminal ROS, TAC, sperm DNA fragmentation, ROS/TAC score were measured.

Result(s)

Group II had a high incidence of sperm DNA fragmentation than group I. The odds ratio of 1.25 for elevated ROS levels corresponded to >10% greater DNA fragmentation in our patients (95% confidence interval 1.01–1.53). Group II showed poor motility, a higher incidence of leukocytospermia, and higher ROS-TAC scores compared with group I. ROS was negatively correlated with sperm curvilinear velocity (r = −.24), linearity (r = −.24), and sperm motility (r = −.31). Sperm motility was correlated with %TUNEL+ve sperm (r = −.39).

Conclusion(s)

An increase in seminal ROS levels by 25% was associated with a 10% increase in sperm DNA fragmentation. Sperm motility was affected by seminal ROS and sperm DNA fragmentation.

Key Words: Sperm motility, sperm motion kinetics, male infertility, sperm DNA fragmentation, oxidative stress, reactive oxygen species, total antioxidant capacity

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 R.M. has nothing to disclose. R.S. has nothing to disclose. A.T. has nothing to disclose. V.K. has nothing to disclose. V.G. has nothing to disclose. E.S. has nothing to disclose. A.A. has nothing to disclose.

 Supported by a grant from the Research Program Committee of the Cleveland Clinic.

PII: S0015-0282(09)04216-2

doi:10.1016/j.fertnstert.2009.12.030

Fertility and Sterility
Volume 94, Issue 6 , Pages 2141-2146, November 2010